UNSW researchers at Black Dog Institute have preliminary evidence that suggests ketamine is effective as an antidepressant when delivered to elderly patients in repeated intravenous doses.
The largest randomised control trial to evaluate the effectiveness of ketamine as a new treatment for major depression has begun across Australia and New Zealand.
We should resist pressure to prescribe ketamine to treat depression until clinical trials on the drug's long-term safety and effectiveness are completed, a leading UNSW mental health expert says.
A drug traditionally used as an anaesthetic and sometimes used recreationally could be effective in preventing suicide in severely depressed patients, says a UNSW academic who has trialled the drug.
Ketamine is being trialled in people with severe depression and is providing almost instant relief from symptoms, offering fresh hope of a quick new way to manage the illness at its worst.
Applying mild electrical currents to the brain has been shown to be an effective treatment for depression. But could the treatment also benefit people with bipolar disorder?
Stimulating the brain with a weak electrical current is a safe and effective treatment for depression and could have other surprise benefits for the body and mind, a major Australian study has found.
A new, non-invasive treatment for depression that delivers barely perceptible electric currents to the scalp has had promising results in a Sydney trial, and researchers are now looking for participants for a follow up study.
UNSW and The Black Dog Institute are seeking participants for a trial of a new, non-invasive form of brain stimulation therapy for depression, known as Direct Current Stimulation (DCS).
